Skip to main content

Table 2 Logistic regression of heart valve operation and death in patients with mitral valve disease

From: Heart valve operations associated with reduced risk of death from mitral valve disease but other operations associated with increased risk of death: a national population-based case–control study

 

Non-matched

Matched

aOR 95% CI

aOR 95% CI

Heart valve operation (reference: non-heart valve operation)

 Yes

0.625 (0.435–0.897)*

0.568 (0.341–0.946)*

Other operation (reference: without)

 Other CVD system operation

1.759 (1.492–2.075)***

2.419 (1.484–3.941)***

 Nervous system operation

1.248 (0.937–1.662)

0.941 (0.395–2.244)

 Digestives system operation

1.715 (1.484–1.982)***

1.222 (0.808–1.849)

 Breath system operation

3.547 (2.959–4.251)***

2.753 (1.694–4.473)***

 Urinary system operation

1.155 (0.911–1.466)

1.915 (1.028–3.568)*

Hemodialysis

5.210 (3.983–6.815)***

7.205 (3.728–13.92)***

 Comorbidity (reference: without)

 Hypertension

1.141 (0.920–1.415)

0.628 (0.366–1.078)

 Hyperlipidemia

0.634 (0.549–0.733)***

0.754 (0.502–1.132)

 Diabetes

1.234 (1.069–1.424)**

1.547 (1.031–2.321)*

 COPD

0.989 (0.855–1.143)

1.085 (0.720–1.634)

 Emphysema

1.575 (1.105–2.245)*

3.046 (1.250–7.420)*

 Heart failure

1.629 (1.402–1.894)***

1.377 (0.878–2.159)

 Cardiac dysrhythmias

1.000 (0.870–1.150)

1.106 (0.737–1.660)

 Anxiety

0.833 (0.720–0.964)*

0.796 (0.523–1.210)

 CKD

1.560 (1.311–1.856)***

2.211 (1.387–3.525)***

 Sleep disturbances

0.872 (0.753–1.010)

0.919 (0.601–1.404)

 Anemia

1.592 (1.369–1.851)***

1.303 (0.825–2.058)

  1. Abbreviation: aOR Adjusted odds ratio, CI Confidence interval, CVD Cardiovascular disease, COPD Chronic obstructive pulmonary disease, CKD Chronic kidney disease
  2. Adiusted with gender, age, low income, other operation, comorbidity.*P < 0.05, **P < 0.01, ***P < 0.001